drugset / Trial / NCT00830843

Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous Sedation

NCT00830843

Phase 4 Completed 13 enrolled Azienda Ospedaliera San Gerardo di Monza
Non-randomizedCrossoverOpen-labelTreatment

Summary

Recent study has shown that inhalatory sedation is a practicable, effective and not risky method in Intensive Care Unit. Sevoflurane effect on cerebral system have been described in previous studies: it causes an increasing of cerebral blood flow and a decrease of oxygen cerebral consumption. Clinical strategy for Subarachnoid Hemorrhage is orientated to increase cerebral blood flow to limit vasospasm phenomena after SAH. Scope of this study is to evaluate the Cerebral Blood Flow variation associated to Isoflurane sedation versus conventional sedation with propofol .

Timeline

Start
2009-01
Primary completion
2011-07
Completion
2011-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified 0.8 % Inhaled
Subject Isoflurane Other / unclassified 1 % Inhaled
Comparator Propofol Small molecule 3 mg/kg Intravenous
Comparator Propofol Small molecule 4 mg/kg Intravenous